Riley O. Mummah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Riley O. Mummah has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- James O. Lloyd-Smith
University of California, Los Angeles
7 shared publications - Evan H. Campbell Grant
U.S. Geological Survey, Eastern Ecological Science Center (Patuxent Wildlife Research Center) S.O. Conte Anadromous Fish Research Laboratory Turners Falls Massachusetts USA
4 shared publications - Katelyn M. Gostic
University of Chicago
3 shared publications - Katherine C. Prager
University of California Los Angeles
3 shared publications - Adam J. Kucharski
Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
2 shared publications Angela H Guglielmino
Department of Ecology and Evolutionary Biology, University of California, Los Angeles, California, United States of America
2 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Diversity and Distributions
- Vol. 32 (11)
Assessing Strategies to Optimize Participatory Science Data in Species Distribution Models
Aims: Data from participatory science projects are widely used to understand species distributions. However, participatory science data often contain biases that can obscure real patterns. We address two sources of sampling bias: location uncertainty of individual records and spatially heterogeneous sampling effort. A variety of data processing and modelling strategies have been used to address these biases, without consensus on their relative effectiveness. We test several strategies using data from iNaturalist, a large repository of participatory science data. Location: Twenty‐four amphibian ranges of varying sizes and locations within the continental United States. Method: We fit species distribution models with iNaturalist data for 24 amphibian species to compare the effectiveness of strategies intended to improve distribution estimates. We examined three categories of strategies: (1) filtering out records with high location uncertainty, (2) thinning to reduce heterogeneous effort, and (3) observation models that account for heterogeneous effort without removing data. We evaluated the predictive accuracy of each approach using validation data from systematic surveys with constant effort and known locations. Results: The strategies we tested generally had little effect on predictive accuracy as measured by AUC, with no consistent pattern across species. Instead, we found that the minimal change in performance was influenced by the species‐specific search process, the distribution of records, and the resolution of the analysis. Main Conclusion: None of the strategies we tested consistently improve model performance, but our results provide a foundation for a species‐ and analysis‐specific approach. Further improvement in model performance may require additional information or novel methods.
- 9 November 2026
- Published by Wiley in Diversity and Distributions
- Vol. 32 (11)
Open AccessAssessing Strategies to Optimize Participatory Science Data in Species Distribution Models
Aims: Data from participatory science projects are widely used to understand species distributions. However, participatory science data often contain biases that can obscure real patterns. We address two sources of sampling bias: location uncertainty of individual records and spatially heterogeneous sampling effort. A variety of data processing and modelling strategies have been used to address these biases, without consensus on their relative effectiveness. We test several strategies using data from iNaturalist, a large repository of participatory science data. Location: Twenty‐four amphibian ranges of varying sizes and locations within the continental United States. Method: We fit species distribution models with iNaturalist data for 24 amphibian species to compare the effectiveness of strategies intended to improve distribution estimates. We examined three categories of strategies: (1) filtering out records with high location uncertainty, (2) thinning to reduce heterogeneous effort, and (3) observation models that account for heterogeneous effort without removing data. We evaluated the predictive accuracy of each approach using validation data from systematic surveys with constant effort and known locations. Results: The strategies we tested generally had little effect on predictive accuracy as measured by AUC, with no consistent pattern across species. Instead, we found that the minimal change in performance was influenced by the species‐specific search process, the distribution of records, and the resolution of the analysis. Main Conclusion: None of the strategies we tested consistently improve model performance, but our results provide a foundation for a species‐ and analysis‐specific approach. Further improvement in model performance may require additional information or novel methods.
- Open Access
The value of reducing uncertainties to support the management of a high‐elevation endemic salamander
Many salamander populations are declining, and methods to determine how best to allocate limited resources to slow or reverse these declines could support land managers in their decision‐making processes. Multiple types of uncertainty may delay management decisions, including when (1) knowledge of a species' ecology is incomplete, (2) climate change effects on environmental covariates are uncertain, and (3) the efficacy of management alternatives is unknown. For management decisions, a value‐of‐information analysis can identify which uncertainties are critical to reduce in order to identify an optimal strategy from a set of possible management actions. If the same management action is optimal across the full range of uncertainties, then resources for research can be redirected toward active management. Using value‐of‐information analyses, we examine the effect of uncertainty on identifying optimal management to maximize the future expected occupancy of Plethodon shenandoah , a Federally Endangered high‐elevation endemic salamander that is threatened by climate change. Out of 11 management actions proposed by National Park Service managers, those that increase environmental moisture are expected to maximize occupancy, and we find that the selection of this action is robust to all the identified uncertainties. We show that, even in systems with multiple sources of large uncertainty, value of information analyses discriminate among investments in species management.
Open AccessThe value of reducing uncertainties to support the management of a high‐elevation endemic salamander
Many salamander populations are declining, and methods to determine how best to allocate limited resources to slow or reverse these declines could support land managers in their decision‐making processes. Multiple types of uncertainty may delay management decisions, including when (1) knowledge of a species' ecology is incomplete, (2) climate change effects on environmental covariates are uncertain, and (3) the efficacy of management alternatives is unknown. For management decisions, a value‐of‐information analysis can identify which uncertainties are critical to reduce in order to identify an optimal strategy from a set of possible management actions. If the same management action is optimal across the full range of uncertainties, then resources for research can be redirected toward active management. Using value‐of‐information analyses, we examine the effect of uncertainty on identifying optimal management to maximize the future expected occupancy of Plethodon shenandoah , a Federally Endangered high‐elevation endemic salamander that is threatened by climate change. Out of 11 management actions proposed by National Park Service managers, those that increase environmental moisture are expected to maximize occupancy, and we find that the selection of this action is robust to all the identified uncertainties. We show that, even in systems with multiple sources of large uncertainty, value of information analyses discriminate among investments in species management.
- Open Access
- 4 October 2024
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 18 (10) , e0012042
Navigating cross-reactivity and host species effects in a serological assay: A case study of the microscopic agglutination test for Leptospira serology
Background: Serology (the detection of antibodies formed by the host against an infecting pathogen) is frequently used to assess current infections and past exposure to specific pathogens. However, the presence of cross-reactivity among host antibodies in serological data makes it challenging to interpret the patterns and draw reliable conclusions about the infecting pathogen or strain. Methodology/Principal findings: In our study, we use microscopic agglutination test (MAT) serological data from three host species [California sea lion (Zalophus californianus), island fox (Urocyon littoralis), and island spotted skunk (Spilogale gracilis)] with confirmed infections to assess differences in cross-reactivity by host species and diagnostic laboratory. All host species are known to be infected with the same serovar of Leptospira interrogans. We find that absolute and relative antibody titer magnitudes vary systematically across host species and diagnostic laboratories. Despite being infected by the same Leptospira serovar, three host species exhibit different cross-reactivity profiles to a 5-serovar diagnostic panel. We also observe that the cross-reactive antibody titer against a non-infecting serovar can remain detectable after the antibody titer against the infecting serovar declines below detectable levels. Conclusions/Significance: Cross-reactivity in serological data makes interpretation difficult and can lead to common pitfalls. Our results show that the highest antibody titer is not a reliable indicator of infecting serovar and highlight an intriguing role of host species in shaping reactivity patterns. On the other side, seronegativity against a given serovar does not rule out that serovar as the cause of infection. We show that titer magnitudes can be influenced by both host species and diagnostic laboratory, indicating that efforts to interpret absolute titers (e.g., as indicators of recent infection) must be calibrated to the system under study. Thus, we implore scientists and health officials using serological data for surveillance to interpret the data with caution.
- 4 October 2024
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 18 (10) , e0012042
Open AccessNavigating cross-reactivity and host species effects in a serological assay: A case study of the microscopic agglutination test for Leptospira serology
Background: Serology (the detection of antibodies formed by the host against an infecting pathogen) is frequently used to assess current infections and past exposure to specific pathogens. However, the presence of cross-reactivity among host antibodies in serological data makes it challenging to interpret the patterns and draw reliable conclusions about the infecting pathogen or strain. Methodology/Principal findings: In our study, we use microscopic agglutination test (MAT) serological data from three host species [California sea lion (Zalophus californianus), island fox (Urocyon littoralis), and island spotted skunk (Spilogale gracilis)] with confirmed infections to assess differences in cross-reactivity by host species and diagnostic laboratory. All host species are known to be infected with the same serovar of Leptospira interrogans. We find that absolute and relative antibody titer magnitudes vary systematically across host species and diagnostic laboratories. Despite being infected by the same Leptospira serovar, three host species exhibit different cross-reactivity profiles to a 5-serovar diagnostic panel. We also observe that the cross-reactive antibody titer against a non-infecting serovar can remain detectable after the antibody titer against the infecting serovar declines below detectable levels. Conclusions/Significance: Cross-reactivity in serological data makes interpretation difficult and can lead to common pitfalls. Our results show that the highest antibody titer is not a reliable indicator of infecting serovar and highlight an intriguing role of host species in shaping reactivity patterns. On the other side, seronegativity against a given serovar does not rule out that serovar as the cause of infection. We show that titer magnitudes can be influenced by both host species and diagnostic laboratory, indicating that efforts to interpret absolute titers (e.g., as indicators of recent infection) must be calibrated to the system under study. Thus, we implore scientists and health officials using serological data for surveillance to interpret the data with caution.
- Open Access
- 24 May 2024
- Published by Wiley in Conservation Biology
- Vol. 38 (4) , e14284
Reframing wildlife disease management problems with decision analysis
Contemporary wildlife disease management is complex because managers need to respond to a wide range of stakeholders, multiple uncertainties, and difficult trade‐offs that characterize the interconnected challenges of today. Despite general acknowledgment of these complexities, managing wildlife disease tends to be framed as a scientific problem, in which the major challenge is lack of knowledge. The complex and multifactorial process of decision‐making is collapsed into a scientific endeavor to reduce uncertainty. As a result, contemporary decision‐making may be oversimplified, rely on simple heuristics, and fail to account for the broader legal, social, and economic context in which the decisions are made. Concurrently, scientific research on wildlife disease may be distant from this decision context, resulting in information that may not be directly relevant to the pertinent management questions. We propose reframing wildlife disease management challenges as decision problems and addressing them with decision analytical tools to divide the complex problems into more cognitively manageable elements. In particular, structured decision‐making has the potential to improve the quality, rigor, and transparency of decisions about wildlife disease in a variety of systems. Examples of management of severe acute respiratory syndrome coronavirus 2, white‐nose syndrome, avian influenza, and chytridiomycosis illustrate the most common impediments to decision‐making, including competing objectives, risks, prediction uncertainty, and limited resources.
- 24 May 2024
- Published by Wiley in Conservation Biology
- Vol. 38 (4) , e14284
Open AccessReframing wildlife disease management problems with decision analysis
Contemporary wildlife disease management is complex because managers need to respond to a wide range of stakeholders, multiple uncertainties, and difficult trade‐offs that characterize the interconnected challenges of today. Despite general acknowledgment of these complexities, managing wildlife disease tends to be framed as a scientific problem, in which the major challenge is lack of knowledge. The complex and multifactorial process of decision‐making is collapsed into a scientific endeavor to reduce uncertainty. As a result, contemporary decision‐making may be oversimplified, rely on simple heuristics, and fail to account for the broader legal, social, and economic context in which the decisions are made. Concurrently, scientific research on wildlife disease may be distant from this decision context, resulting in information that may not be directly relevant to the pertinent management questions. We propose reframing wildlife disease management challenges as decision problems and addressing them with decision analytical tools to divide the complex problems into more cognitively manageable elements. In particular, structured decision‐making has the potential to improve the quality, rigor, and transparency of decisions about wildlife disease in a variety of systems. Examples of management of severe acute respiratory syndrome coronavirus 2, white‐nose syndrome, avian influenza, and chytridiomycosis illustrate the most common impediments to decision‐making, including competing objectives, risks, prediction uncertainty, and limited resources.
- Open Access
Navigating cross-reactivity and host species effects in a serological assay: A case study of the microscopic agglutination test for Leptospira serology
Background: Serology (the detection of antibodies formed by the host against an infecting pathogen) is frequently used to assess current infections and past exposure to specific pathogens. However, the presence of cross-reactivity among host antibodies in serological data makes it challenging to interpret the patterns and draw reliable conclusions about the infecting pathogen or strain. Methodology/Principal Findings: In our study, we use microscopic agglutination test (MAT) serological data from three host species [California sea lion ( Zalophus californianus ), island fox ( Urocyon littoralis ), and island spotted skunk ( Spilogale gracilis )] with confirmed infections to assess differences in cross-reactivity by host species and diagnostic laboratory. All host species are known to be infected with the same serovar of Leptospira interrogans . We find that absolute and relative antibody titer magnitudes vary systematically across host species and diagnostic laboratories. Despite being infected by the same Leptospira serovar, three host species exhibit different cross-reactivity profiles to a 5-serovar diagnostic panel. We also observe that the cross-reactive antibody titer against a non-infecting serovar can remain detectable after the antibody titer against the infecting serovar declines below detectable levels. Conclusions/Significance: Cross-reactivity in serological data makes interpretation difficult and can lead to common pitfalls. Our results show that the highest antibody titer is not a reliable indicator of infecting serovar and highlight an intriguing role of host species in shaping reactivity patterns. On the other side, seronegativity against a given serovar does not rule out that serovar as the cause of infection. We show that titer magnitudes can be influenced by both host species and diagnostic laboratory, indicating that efforts to interpret absolute titer levels (e.g., as indicators of recent infection) must be calibrated to the system under study. Thus, we implore scientists and health officials using serological data for surveillance to interpret the data with caution. AUTHOR SUMMARY: Serology is frequently used for disease surveillance, especially in systems that are resource constrained or logistically challenging. Serological testing involves analyzing blood serum samples to detect antibodies with reactivity toward specific pathogens (or more generally, molecular antigens), with the goal of characterizing past exposure to those pathogens. However, these antibodies can be non-specific and may react against other related pathogens or strains – a phenomenon known as cross-reactivity. Interpretation of serological data exhibiting cross-reactivity is difficult and simplifying assumptions are often made (e.g., to interpret the strain that elicits the highest antibody titer level as the infecting pathogen strain). Our work shows that interpreting antibody data requires more nuance and more caution. Both absolute titer levels and relative reactivity against different strains can vary across host species and diagnostic laboratories, so it is essential to interpret these data in the appropriate context. These host species differences in antibody reactivity and cross-reactivity patterns make direct comparisons across species inadvisable.
Open AccessNavigating cross-reactivity and host species effects in a serological assay: A case study of the microscopic agglutination test for Leptospira serology
Background: Serology (the detection of antibodies formed by the host against an infecting pathogen) is frequently used to assess current infections and past exposure to specific pathogens. However, the presence of cross-reactivity among host antibodies in serological data makes it challenging to interpret the patterns and draw reliable conclusions about the infecting pathogen or strain. Methodology/Principal Findings: In our study, we use microscopic agglutination test (MAT) serological data from three host species [California sea lion ( Zalophus californianus ), island fox ( Urocyon littoralis ), and island spotted skunk ( Spilogale gracilis )] with confirmed infections to assess differences in cross-reactivity by host species and diagnostic laboratory. All host species are known to be infected with the same serovar of Leptospira interrogans . We find that absolute and relative antibody titer magnitudes vary systematically across host species and diagnostic laboratories. Despite being infected by the same Leptospira serovar, three host species exhibit different cross-reactivity profiles to a 5-serovar diagnostic panel. We also observe that the cross-reactive antibody titer against a non-infecting serovar can remain detectable after the antibody titer against the infecting serovar declines below detectable levels. Conclusions/Significance: Cross-reactivity in serological data makes interpretation difficult and can lead to common pitfalls. Our results show that the highest antibody titer is not a reliable indicator of infecting serovar and highlight an intriguing role of host species in shaping reactivity patterns. On the other side, seronegativity against a given serovar does not rule out that serovar as the cause of infection. We show that titer magnitudes can be influenced by both host species and diagnostic laboratory, indicating that efforts to interpret absolute titer levels (e.g., as indicators of recent infection) must be calibrated to the system under study. Thus, we implore scientists and health officials using serological data for surveillance to interpret the data with caution. AUTHOR SUMMARY: Serology is frequently used for disease surveillance, especially in systems that are resource constrained or logistically challenging. Serological testing involves analyzing blood serum samples to detect antibodies with reactivity toward specific pathogens (or more generally, molecular antigens), with the goal of characterizing past exposure to those pathogens. However, these antibodies can be non-specific and may react against other related pathogens or strains – a phenomenon known as cross-reactivity. Interpretation of serological data exhibiting cross-reactivity is difficult and simplifying assumptions are often made (e.g., to interpret the strain that elicits the highest antibody titer level as the infecting pathogen strain). Our work shows that interpreting antibody data requires more nuance and more caution. Both absolute titer levels and relative reactivity against different strains can vary across host species and diagnostic laboratories, so it is essential to interpret these data in the appropriate context. These host species differences in antibody reactivity and cross-reactivity patterns make direct comparisons across species inadvisable.
- Open Access
- 21 August 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (10) , 2654-2667
Inferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology would benefit greatly from knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody‐level data being one of the most promising sources of information. The use of antibody levels to back‐calculate infection time requires the development of a host‐pathogen system‐specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. We present a way to model antibody dynamics in a Bayesian framework that facilitates the incorporation of all available information about potential infection times and apply the model to estimate infection times of Channel Island foxes infected withLeptospira interrogans. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements in infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. When applied to field data we saw reductions up to 83% in the window of possible infection times. The method substantially simplifies the challenge of modelling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology and can even be applied to cross‐sectional data once the model is trained.
- 21 August 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (10) , 2654-2667
Open AccessInferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology would benefit greatly from knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody‐level data being one of the most promising sources of information. The use of antibody levels to back‐calculate infection time requires the development of a host‐pathogen system‐specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. We present a way to model antibody dynamics in a Bayesian framework that facilitates the incorporation of all available information about potential infection times and apply the model to estimate infection times of Channel Island foxes infected withLeptospira interrogans. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements in infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. When applied to field data we saw reductions up to 83% in the window of possible infection times. The method substantially simplifies the challenge of modelling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology and can even be applied to cross‐sectional data once the model is trained.
- Open Access
- 11 April 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (5) , 1299-1311
Inferring pathogen presence when sample misclassification and partial observation occur
Surveillance programmes are essential for detecting emerging pathogens and often rely on molecular methods to make inference about the presence of a target disease agent. However, molecular methods rarely detect target DNA perfectly. For example, molecular pathogen detection methods can result in misclassification (i.e. false positives and false negatives) or partial detection errors (i.e. detections with ‘ambiguous’, ‘uncertain’ or ‘equivocal’ results). Then, when data are to be analysed, these partial observations are either discarded or censored; this, however, disregards information that could be used to make inference about the true state of the system. There is a critical need for more direction and guidance related to how many samples are enough to declare a unit of interest ‘pathogen free’. Here, we develop a Bayesian hierarchal framework that accommodates false negative, false positive and uncertain detections to improve inference related to the occupancy of a pathogen. We apply our modelling framework to a case study of the fungal pathogen Pseudogymnoascus destructans (Pd) identified in Texas bats at the invasion front of white‐nose syndrome. To improve future surveillance programmes, we provide guidance on sample sizes required to be 95% certain a target organism is absent from a site. We found that the presence of uncertain detections increased the variability of resulting posterior probability distributions of pathogen occurrence, and that our estimates of required sample size were very sensitive to prior information about pathogen occupancy, pathogen prevalence and diagnostic test specificity. In the Pd case study, we found that the posterior probability of occupancy was very low in 2018, but occupancy probability approached 1 in 2020, reflecting increasing prior probabilities of occupancy and prevalence elicited from the site manager. Our modelling framework provides the user a posterior probability distribution of pathogen occurrence, which allows for subjective interpretation by the decision‐maker. To help readers apply and use the methods we developed, we provide an interactive RShiny app that generates target species occupancy estimation and sample size estimates to make these methods more accessible to the scientific community (https://rmummah.shinyapps.io/ambigDetect_sampleSize). This modelling framework and sample size guide may be useful for improving inferences from molecular surveillance data about emerging pathogens, non‐native invasive species and endangered species where misclassifications and ambiguous detections occur.
- 11 April 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (5) , 1299-1311
Open AccessInferring pathogen presence when sample misclassification and partial observation occur
Surveillance programmes are essential for detecting emerging pathogens and often rely on molecular methods to make inference about the presence of a target disease agent. However, molecular methods rarely detect target DNA perfectly. For example, molecular pathogen detection methods can result in misclassification (i.e. false positives and false negatives) or partial detection errors (i.e. detections with ‘ambiguous’, ‘uncertain’ or ‘equivocal’ results). Then, when data are to be analysed, these partial observations are either discarded or censored; this, however, disregards information that could be used to make inference about the true state of the system. There is a critical need for more direction and guidance related to how many samples are enough to declare a unit of interest ‘pathogen free’. Here, we develop a Bayesian hierarchal framework that accommodates false negative, false positive and uncertain detections to improve inference related to the occupancy of a pathogen. We apply our modelling framework to a case study of the fungal pathogen Pseudogymnoascus destructans (Pd) identified in Texas bats at the invasion front of white‐nose syndrome. To improve future surveillance programmes, we provide guidance on sample sizes required to be 95% certain a target organism is absent from a site. We found that the presence of uncertain detections increased the variability of resulting posterior probability distributions of pathogen occurrence, and that our estimates of required sample size were very sensitive to prior information about pathogen occupancy, pathogen prevalence and diagnostic test specificity. In the Pd case study, we found that the posterior probability of occupancy was very low in 2018, but occupancy probability approached 1 in 2020, reflecting increasing prior probabilities of occupancy and prevalence elicited from the site manager. Our modelling framework provides the user a posterior probability distribution of pathogen occurrence, which allows for subjective interpretation by the decision‐maker. To help readers apply and use the methods we developed, we provide an interactive RShiny app that generates target species occupancy estimation and sample size estimates to make these methods more accessible to the scientific community (https://rmummah.shinyapps.io/ambigDetect_sampleSize). This modelling framework and sample size guide may be useful for improving inferences from molecular surveillance data about emerging pathogens, non‐native invasive species and endangered species where misclassifications and ambiguous detections occur.
- Open Access
Inferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology often rely heavily on knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody level data being one of the most promising sources of information. The use of antibody levels to back-calculate infection time requires the development of a host-pathogen system-specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. Here, we present a way to do this in a Bayesian framework that facilitates the incorporation of all available information about potential infection times. We apply the model to estimate infection times of Channel Island foxes infected with Leptospira interrogans , leading to reductions of 51-92% in the window of possible infection times. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements of infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. The method substantially simplifies the challenge of modeling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology, and can even be applied to cross-sectional data once the model is trained.
Open AccessInferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology often rely heavily on knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody level data being one of the most promising sources of information. The use of antibody levels to back-calculate infection time requires the development of a host-pathogen system-specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. Here, we present a way to do this in a Bayesian framework that facilitates the incorporation of all available information about potential infection times. We apply the model to estimate infection times of Channel Island foxes infected with Leptospira interrogans , leading to reductions of 51-92% in the window of possible infection times. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements of infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. The method substantially simplifies the challenge of modeling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology, and can even be applied to cross-sectional data once the model is trained.
- Open Access
- 18 September 2020
- Published by Springer Nature in One Health Outlook
- Vol. 2 (1) , 1-15
Controlling emerging zoonoses at the animal-human interface
Background: For many emerging or re-emerging pathogens, cases in humans arise from a mixture of introductions (via zoonotic spillover from animal reservoirs or geographic spillover from endemic regions) and secondary human-to-human transmission. Interventions aiming to reduce incidence of these infections can be focused on preventing spillover or reducing human-to-human transmission, or sometimes both at once, and typically are governed by resource constraints that require policymakers to make choices. Despite increasing emphasis on using mathematical models to inform disease control policies, little attention has been paid to guiding rational disease control at the animal-human interface.Methods: We introduce a modeling framework to analyze the impacts of different disease control policies, focusing on pathogens exhibiting subcritical transmission among humans (i.e. pathogens that cannot establish sustained human-to-human transmission). We quantify the relative effectiveness of measures to reduce spillover (e.g. reducing contact with animal hosts), human-to-human transmission (e.g. case isolation), or both at once (e.g. vaccination), across a range of epidemiological contexts.Results: We provide guidelines for choosing which mode of control to prioritize in different epidemiological scenarios and considering different levels of resource and relative costs. We contextualize our analysis with current zoonotic pathogens and other subcritical pathogens, such as post-elimination measles, and control policies that have been applied.Conclusions: Our work provides a model-based, theoretical foundation to understand and guide policy for subcritical zoonoses, integrating across disciplinary and species boundaries in a manner consistent with One Health principles.
- 18 September 2020
- Published by Springer Nature in One Health Outlook
- Vol. 2 (1) , 1-15
Open AccessControlling emerging zoonoses at the animal-human interface
Background: For many emerging or re-emerging pathogens, cases in humans arise from a mixture of introductions (via zoonotic spillover from animal reservoirs or geographic spillover from endemic regions) and secondary human-to-human transmission. Interventions aiming to reduce incidence of these infections can be focused on preventing spillover or reducing human-to-human transmission, or sometimes both at once, and typically are governed by resource constraints that require policymakers to make choices. Despite increasing emphasis on using mathematical models to inform disease control policies, little attention has been paid to guiding rational disease control at the animal-human interface.Methods: We introduce a modeling framework to analyze the impacts of different disease control policies, focusing on pathogens exhibiting subcritical transmission among humans (i.e. pathogens that cannot establish sustained human-to-human transmission). We quantify the relative effectiveness of measures to reduce spillover (e.g. reducing contact with animal hosts), human-to-human transmission (e.g. case isolation), or both at once (e.g. vaccination), across a range of epidemiological contexts.Results: We provide guidelines for choosing which mode of control to prioritize in different epidemiological scenarios and considering different levels of resource and relative costs. We contextualize our analysis with current zoonotic pathogens and other subcritical pathogens, such as post-elimination measles, and control policies that have been applied.Conclusions: Our work provides a model-based, theoretical foundation to understand and guide policy for subcritical zoonoses, integrating across disciplinary and species boundaries in a manner consistent with One Health principles.
- Open Access
- 15 June 2020
- Published by Wiley in Ecology and Evolution
- Vol. 10 (14) , 7221-7232
Estimating prevalence and test accuracy in disease ecology: How Bayesian latent class analysis can boost or bias imperfect test results
Obtaining accurate estimates of disease prevalence is crucial for the monitoring and management of wildlife populations but can be difficult if different diagnostic tests yield conflicting results and if the accuracy of each diagnostic test is unknown. Bayesian latent class analysis (BLCA) modeling offers a potential solution, providing estimates of prevalence levels and diagnostic test accuracy under the realistic assumption that no diagnostic test is perfect. In typical applications of this approach, the specificity of one test is fixed at or close to 100%, allowing the model to simultaneously estimate the sensitivity and specificity of all other tests, in addition to infection prevalence. In wildlife systems, a test with near‐perfect specificity is not always available, so we simulated data to investigate how decreasing this fixed specificity value affects the accuracy of model estimates. We used simulations to explore how the trade‐off between diagnostic test specificity and sensitivity impacts prevalence estimates and found that directional biases depend on pathogen prevalence. Both the precision and accuracy of results depend on the sample size, the diagnostic tests used, and the true infection prevalence, so these factors should be considered when applying BLCA to estimate disease prevalence and diagnostic test accuracy in wildlife systems. A wildlife disease case study, focusing on leptospirosis in California sea lions, demonstrated the potential for Bayesian latent class methods to provide reliable estimates under real‐world conditions. We delineate conditions under which BLCA improves upon the results from a single diagnostic across a range of prevalence levels and sample sizes, demonstrating when this method is preferable for disease ecologists working in a wide variety of pathogen systems.
- 15 June 2020
- Published by Wiley in Ecology and Evolution
- Vol. 10 (14) , 7221-7232
Open AccessEstimating prevalence and test accuracy in disease ecology: How Bayesian latent class analysis can boost or bias imperfect test results
Obtaining accurate estimates of disease prevalence is crucial for the monitoring and management of wildlife populations but can be difficult if different diagnostic tests yield conflicting results and if the accuracy of each diagnostic test is unknown. Bayesian latent class analysis (BLCA) modeling offers a potential solution, providing estimates of prevalence levels and diagnostic test accuracy under the realistic assumption that no diagnostic test is perfect. In typical applications of this approach, the specificity of one test is fixed at or close to 100%, allowing the model to simultaneously estimate the sensitivity and specificity of all other tests, in addition to infection prevalence. In wildlife systems, a test with near‐perfect specificity is not always available, so we simulated data to investigate how decreasing this fixed specificity value affects the accuracy of model estimates. We used simulations to explore how the trade‐off between diagnostic test specificity and sensitivity impacts prevalence estimates and found that directional biases depend on pathogen prevalence. Both the precision and accuracy of results depend on the sample size, the diagnostic tests used, and the true infection prevalence, so these factors should be considered when applying BLCA to estimate disease prevalence and diagnostic test accuracy in wildlife systems. A wildlife disease case study, focusing on leptospirosis in California sea lions, demonstrated the potential for Bayesian latent class methods to provide reliable estimates under real‐world conditions. We delineate conditions under which BLCA improves upon the results from a single diagnostic across a range of prevalence levels and sample sizes, demonstrating when this method is preferable for disease ecologists working in a wide variety of pathogen systems.